Advances in preclinical and clinical studies of oncolytic virus combination therapy
Oncolytic viruses represent a distinct class of viruses that selectively infect and destroy tumor cells while sparing normal cells. Despite their potential, oncolytic viruses encounter several challenges as standalone therapies. Consequently, the combination of oncolytic viruses with other therapeut...
Saved in:
Main Authors: | Wenlong Du, Jintong Na, Liping Zhong, Pumin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1545542/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic advancements in breast cancer treatment: a review
by: Marzieh Shokoohi, et al.
Published: (2025-02-01) -
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
by: Fang Wang, et al.
Published: (2025-02-01) -
Levistolide A and periplogenin inhibit the growth of gastric cancer cells in vitro and in vivo
by: Jia Li Guo, et al.
Published: (2023-03-01) -
The combined method of rectocele treatment
by: A. M. Kuzminov, et al.
Published: (2013-07-01) -
Manipulating the cGAS-STING Axis: advancing innovative strategies for osteosarcoma therapeutics
by: BingBing Li, et al.
Published: (2025-02-01)